Skip to content

Serotonin: all studies

Page 194 of 400: studies 1,931 to 1,940 of 3,999, newest first. Back to the serotonin overview

Research

Ecstasy (MDMA) for social anxiety in autism: a specialized application of empathogen therapy

Annals of Medicine and Surgery April 6, 2026 Mahnoor Sheikh, Zaibunnisa Bilal, Syeda Habiba Fatima et al.

To the Editor, Autism spectrum disorder (ASD) is a neurodevelopmental state in which there are early emerging problems in social communication along with fixed behavior patterns. Social difficulties in ASD are characterized by difficulty in interpretation of interpersonal signals such as facial expressions, tone of voice, and body language. Individuals with ASD often present with social...

DOI: 10.1097/ms9.0000000000004936 (opens in new tab) Ecstasy Social anxiety Social skills Social inhibition +14

POTENCIAL TERAPÊUTICO DA HOASCA NO TRATAMENTO DA DEPRESSÃO: REVISÃO DE ESCOPO

Revista Políticas Públicas & Cidades April 2, 2026 Adrian Santos de Souza, Endiamara Magda Segala Shigemori, Celso Ferraz Bett

A depressão é uma das principais causas de incapacidade no mundo, e suas abordagens terapêuticas convencionais, embora eficazes para muitos pacientes, ainda apresentam limitações significativas, como início tardio dos efeitos e resistência ao tratamento. Nesse contexto, destaca-se a hoasca, também conhecida como ayahuasca, uma infusão amazônica tradicional composta por Banisteriopsis caapi e...

DOI: 10.23900/2359-1552v15n4-4-2026 (opens in new tab) Context archaeology Scielo Gynecology

The Efficacy and Safety of Ibogaine Treatment for Substance Use Disorders - A Narrative Review

Quality in Sport April 2, 2026 Milena Majchrzyk, Weronika Walendziak, Magdalena Ostaszewska et al.

Introduction and aim of the study. Substance use disorders, including opioid, cocaine, and alcohol dependence, represent a significant global health challenge with high relapse rates despite existing treatments. Ibogaine, a naturally occurring indole alkaloid derived from Tabernanthe iboga, has attracted increasing scientific interest due to its reported ability to reduce withdrawal symptoms...

DOI: 10.12775/qs.2026.54.69942 (opens in new tab) Context archaeology Narrative review Cardiotoxicity Substance use +11

361 Effect of intravenous psilocybin on mechanical hypersensitivity in a rat model of reserpine-induced chronic centralized pain

Journal of Clinical and Translational Science April 1, 2026 Emma R. Huels, S. Smith, Tiecheng Liu et al.

Objectives/Goals: We recently showed that a single dose of psilocybin, a serotonergic psychedelic, attenuated mechanical hypersensitivity for up to 28 days in a rat model of formalin-induced chronic centralized pain. The goal of this study is to determine whether psilocybin can alleviate chronic pain in a rat model of reserpine-induced chronic centralized pain. Methods/Study Population: Adult...

Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications

FOCUS: The Journal of Lifelong Learning in Psychiatry April 1, 2026 Shakila Meshkat, Manish K. Jha, Venkat Bhat

Psilocybin, a serotonergic psychedelic, has gained attention as a potential treatment for various psychiatric conditions. In this review, the authors summarize current clinical evidence related to psilocybin’s efficacy, safety, and mechanisms of action across psychiatric disorders. Findings from early-phase and small-scale clinical trials suggest rapid but variable reductions in depressive...

DOI: 10.1176/appi.focus.20250043 (opens in new tab) Psilocybin Depression economics Schizophrenia object-oriented programming Medline +1

TUSI Valve: Echocardiographic and Pathologic Correlates of a Novel Drug-Induced Valvular Disease-a Case Series.

CASE April 1, 2026 Juan Felipe Vasquez-Rodriguez, Gustavo Lemus-Barrios, Diego Rangel-Rivera et al.

• TUSI ("pink cocaine") use may cause serotonin-mediated drug-induced valvular disease. • Echocardiography shows reproducible thickening and restricted atrioventricular valve motion. • Histology reveals myxoid degeneration without inflammatory infiltrate. • Young patients with unexplained regurgitation require drug-use screening. • Synthetic drug use poses emerging cardiovascular risks needing...

DOI: 10.1016/j.case.2026.01.003 (opens in new tab) Full text (opens in new tab) 3,4-methylenedioxymethamphetamine Echocardiography Heart valve diseases Tusi

Psilocybin mitigates chronic behavioral and neurobiological alterations in a rat model of recurrent intimate partner violence-related brain injury.

Molecular Psychiatry April 1, 2026 Josh Allen, Mujun Sun, Tamara L Baker et al. 1 citation

Intimate partner violence (IPV) poses a significant medical concern, predominantly affecting females. IPV-related brain injuries (IPV-BI), such as mild traumatic brain injury (mTBI) and non-fatal strangulation (NFS), sustained during physical attacks are common and often repetitive. Chronic neurobehavioral sequalae from IPV-BI are associated with neuroinflammation and impaired neuroplasticity,...

Classic psychedelics in obsessive–compulsive disorder: a circuit-based framework

Nature Mental Health April 1, 2026 Saif S. Ali, Robin Carhart-Harris, Karl G. Sieg

Obsessive–compulsive disorder (OCD) is a psychiatric condition with high rates of treatment resistance. Emerging neuroimaging evidence implicates dysfunction in large-scale brain networks, particularly the cortico–striatal–thalamo–cortical (CSTC) circuit, default mode network (DMN) and salience network (SN). Lysergic acid diethylamide (LSD) and psilocybin induce acute dysregulation of the DMN...

Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action.

Pharmacology Research & Perspectives April 1, 2026 Jordana Kazdan, Karim S Ladha, Muhammad Ishrat Husain

Major Depressive Disorder (MDD) and chronic pain are independently debilitating conditions that frequently co-occur. This comorbidity poses a significant clinical challenge, resulting in greater symptom severity, higher disability, and worse prognosis than either condition alone. Current therapies often address each disorder in isolation, leaving individuals with comorbid MDD and chronic pain...

Wherefore the Magic? The Evolutionary Role of Psilocybin in Nature

Ecology and Evolution April 1, 2026 Kirsty J. Matthews Nicholass, Ilona Flis, Me Hanley et al.

ABSTRACT Research into psychedelic compounds is in resurgence because of the exciting potential for their use in the treatment of psychiatric and mental health disorders. Despite this revival, remarkably little is known about their evolution. One of the most intriguing psychedelic compounds is psilocybin, the compound found in ‘magic’ mushrooms and used in ritual ceremonies in North America for...

DOI: 10.1002/ece3.73522 (opens in new tab) Psilocybin Invertebrate Wing Natural selection +8